G. Parks

发表

Orthomyxoviridae: The Viruses and Their Replication.

R. Lamb, G. Parks, 1996 .

Encephalomyocarditis virus 3C protease: efficient cell-free expression from clones which link viral 5' noncoding sequences to the P3 region

G. Parks, A. C. Palmenberg, G. Duke, 1986, Journal of virology.

Implications of the picornavirus capsid structure for polyprotein processing.

G. Vriend, G. Parks, E. Wimmer, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Engineered Expression of the TLR 5 Ligand Flagellin Enhances Paramyxovirus Activation of Human Dendritic Cell Function

G. Parks, S. Mizel, M. Alexander-Miller, 2008 .

TLR-4 and -6 agonists reverse apoptosis and promote maturation of simian virus 5-infected human dendritic cells through NFkB-dependent pathways.

G. Parks, M. Alexander-Miller, S. Arimilli, 2007, Virology.

Adjuvanting an inactivated influenza vaccine with flagellin improves the function and quantity of the long-term antibody response in a nonhuman primate neonate model.

G. Parks, R. D'Agostino, Beth C. Holbrook, 2016, Vaccine.

A Novel R848-Conjugated Inactivated Influenza Virus Vaccine Is Efficacious and Safe in a Neonate Nonhuman Primate Model

G. Parks, R. D'Agostino, N. Kock, 2016, The Journal of Immunology.

Nonhuman primate infants have an impaired respiratory but not systemic IgG antibody response following influenza virus infection.

G. Parks, N. Kock, Beth C. Holbrook, 2015, Virology.

Inclusion of Flagellin during Vaccination against Influenza Enhances Recall Responses in Nonhuman Primate Neonates

G. Parks, S. Mizel, N. Kock, 2015, Journal of Virology.

Metal-Mediated Nanoscale Cerium Oxide Inactivates Human Coronavirus and Rhinovirus by Surface Disruption

Craig J. Neal, G. Parks, S. Seal, 2021, ACS nano.

Zika virus as an oncolytic treatment of human neuroblastoma cells requires CD24

G. Parks, K. Alexander, Peter E. Phelan, 2018, PloS one.

A Novel RNA Virus System for Selective Killing of Breast Cancer Cells

G. Parks, 2001 .

AD Award l ^ umber : DAMD 17-001-0488 TITLE : A Novel RNA Virus System for Selective Killing of Breast Cancer Cells

G. Parks, 2022 .

A novel process for optimizing musculoskeletal allograft tissue to improve safety, ultrastructural properties, and cell infiltration.

Thomas L. Smith, Patrick W. Whitlock, G. Parks, 2012, The Journal of bone and joint surgery. American volume.

Proteolytic processing of the cardioviral P2 region: primary 2A/2B cleavage in clone-derived precursors.

G. Parks, D. Hall, A. Palmenberg, 1992, Virology.

Influenza-Specific CD 8 Composition of the Ongoing Negatively Modulates the Size and Streptococcus pneumoniae Coinfection with

Martha, G. Parks, Beth C. Holbrook, 2014 .

Coinfection with Streptococcus pneumoniae Negatively Modulates the Size and Composition of the Ongoing Influenza-Specific CD8+ T Cell Response

G. Parks, Beth C. Holbrook, M. Alexander-Miller, 2014, The Journal of Immunology.

Interactions of Human Complement with Virus Particles Containing the Nipah Virus Glycoproteins

G. Parks, Benhur Lee, Hector C. Aguilar, 2011, Journal of Virology.

IFNgamma-producing, virus-specific CD8+ effector cells acquire the ability to produce IL-10 as a result of entry into the infected lung environment.

G. Parks, Beth C. Holbrook, M. Alexander-Miller, 2010, Virology.

Oncolytic parainfluenza virus combines with NK cells to mediate killing of infected and non-infected lung cancer cells within 3D spheroids: role of type I and type III interferon signaling

G. Parks, A. Copik, J. Oyer, 2021, Journal for ImmunoTherapy of Cancer.

Altered Function in CD8+ T Cells following Paramyxovirus Infection of the Respiratory Tract

G. Parks, M. Alexander-Miller, Peter M. Gray, 2005, Journal of Virology.

Altered Function in CD8 (cid:1) T Cells following Paramyxovirus Infection of the Respiratory Tract

G. Parks, M. Alexander-Miller, Peter M. Gray, 2005 .

Modulation of CD8+ T cell avidity by increasing the turnover of viral antigen during infection.

G. Parks, M. Alexander-Miller, Peter M. Gray, 2004, Cellular immunology.

Molecular cloning of the NP and L genes of simian virus 5: identification of highly conserved domains in paramyxovirus NP and L proteins.

R. Lamb, G. Parks, C. D. Ward, 1992, Virus research.

Distinct pathways for signaling maturation in macrophages and dendritic cells after infection with paramyxovirus simian virus 5.

G. Parks, M. Alexander-Miller, S. Pejawar-Gaddy, 2007, Viral immunology.

Transposition of domains between the M2 and HN viral membrane proteins results in polypeptides which can adopt more than one membrane orientation

R. Lamb, G. Parks, J. Hull, 1989, The Journal of cell biology.

CD24 Expression Dampens the Basal Antiviral State in Human Neuroblastoma Cells and Enhances Permissivity to Zika Virus Infection

G. Parks, E. Crowgey, K. Alexander, 2022, Viruses.

Proteolytic cleavage of encephalomyocarditis virus capsid region substrates by precursors to the 3C enzyme

G. Parks, A. C. Palmenberg, A. Palmenberg, 1989, Journal of virology.

ALD based nanostructured zinc oxide coated antiviral silk fabric

G. Parks, P. Banerjee, S. Seal, 2022, RSC advances.

Incorporation of Host Complement Regulatory Proteins into Newcastle Disease Virus Enhances Complement Evasion

G. Parks, J. B. Johnson, Moanaro Biswas, 2012, Journal of Virology.

Differential In Vitro Growth and Cell Killing of Cancer versus Benign Prostate Cells by Oncolytic Parainfluenza Virus

G. Parks, Kritika Kedarinath, 2022, Pathogens.

Folding and oligomerization properties of a soluble and secreted form of the paramyxovirus hemagglutinin-neuraminidase glycoprotein.

R. Lamb, G. Parks, 1990, Virology.

Defective assembly and intracellular transport of mutant paramyxovirus hemagglutinin-neuraminidase proteins containing altered cytoplasmic domains

R. Lamb, G. Parks, 1990, Journal of virology.

Potent Inactivation of Human Respiratory Viruses Including SARS-CoV-2 by a Photoactivated Self-Cleaning Regenerative Antiviral Coating

Craig J. Neal, G. Parks, Yifei Fu, 2022, ACS applied materials & interfaces.

Characterization of Mengo virus neutralization epitopes.

G. Parks, A. C. Palmenberg, U. Boege, 1991, Virology.

Activation of human macrophages by bacterial components relieves the restriction on replication of an interferon-inducing parainfluenza virus 5 (PIV5) P/V mutant.

G. Parks, Robert C. Holder, S. Reid, 2011, Microbes and infection.

Mapping of a region of the paramyxovirus L protein required for the formation of a stable complex with the viral phosphoprotein P

G. Parks, 1994, Journal of virology.

A porcine xenograft‐derived bone scaffold is a biocompatible bone graft substitute: An assessment of cytocompatibility and the alpha‐Gal epitope

Thomas L. Smith, Alexander H. Jinnah, G. Parks, 2019, Xenotransplantation.

Spacing constraints on reinitiation of paramyxovirus transcription: the gene end U tract acts as a spacer to separate gene end from gene start sites.

G. Parks, G. Brewer, G. Wilson, 2000, Virology.

RNA Replication for the Paramyxovirus Simian Virus 5 Requires an Internal Repeated (CGNNNN) Sequence Motif

G. Parks, S. Murphy, 1999, Journal of Virology.

Exploring safety of food truck products in a developed country

G. Parks, S. Sönmez, S. Moore, 2019, International Journal of Hospitality Management.

La Crosse Virus Infection of Human Keratinocytes Leads to Interferon-Dependent Apoptosis of Bystander Non-Infected Cells In Vitro

G. Parks, M. Cruz, 2020, Viruses.

Differential Effects of Changes in the Length of a Signal/Anchor Domain on Membrane Insertion, Subunit Assembly, and Intracellular Transport of a Type II Integral Membrane Protein (*)

G. Parks, 1996, The Journal of Biological Chemistry.

Relative Contribution of Cellular Complement Inhibitors CD59, CD46, and CD55 to Parainfluenza Virus 5 Inhibition of Complement-Mediated Neutralization

G. Parks, Yujia Li, 2018, Viruses.

Parainfluenza Virus Infection Sensitizes Cancer Cells to DNA-Damaging Agents: Implications for Oncolytic Virus Therapy

G. Parks, C. Fox, 2018, Journal of Virology.

Controlled cell killing by a recombinant nonsegmented negative-strand RNA virus.

G. Parks, C. Koumenis, V. A. Young, 2002, Virology.

The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2.

R. Lamb, G. Parks, C. Horvath, 2001, Virology.

Replication-independent activation of human plasmacytoid dendritic cells by the paramyxovirus SV5 Requires TLR7 and autophagy pathways.

G. Parks, Caitlin M. Briggs, Mary J Manuse, 2010, Virology.

Topology of eukaryotic type II membrane proteins: Importance of N-terminal positively charged residues flanking the hydrophobic domain

R. Lamb, G. Parks, 1991, Cell.

Enhancement of Infectivity of Insect Cell-Derived La Crosse Virus by Human Serum.

G. Parks, M. Cruz, 2020, Virus research.

Increased Readthrough Transcription across the Simian Virus 5 M-F Gene Junction Leads to Growth Defects and a Global Inhibition of Viral mRNA Synthesis

G. Parks, J. Rassa, K. R. Ward, 2001, Journal of Virology.

Highly Diverse Intergenic Regions of the Paramyxovirus Simian Virus 5 Cooperate with the Gene End U Tract in Viral Transcription Termination and Can Influence Reinitiation at a Downstream Gene

G. Parks, J. Rassa, 1999, Journal of Virology.

Histone Deacetylase Inhibitors Enhance Cell Killing and Block Interferon-Beta Synthesis Elicited by Infection with an Oncolytic Parainfluenza Virus

G. Parks, C. Fox, 2019, Viruses.

Antiviral activity and RNA polymerase degradation following Hsp90 inhibition in a range of negative strand viruses.

G. Parks, J. Connor, D. Lyles, 2007, Virology.

An Alphavirus-Based Adjuvant Enhances Serum and Mucosal Antibodies, T Cells, and Protective Immunity to Influenza Virus in Neonatal Mice

G. Parks, R. Johnston, S. Khalil, 2014, Journal of Virology.

An Alphavirus-based Adjuvant Enhances Serum and Mucosal Antibodies, T cells and Protective 2

G. Parks, R. Johnston, S. Khalil, 2014 .

in Neonatal Mice and Protective Immunity to Influenza Virus Serum and Mucosal Antibodies , T Cells , An Alphavirus-Based Adjuvant Enhances

G. Parks, R. Johnston, S. Khalil, 2014 .

Molecular basis for naturally occurring elevated readthrough transcription across the M-F junction of the paramyxovirus SV5.

G. Parks, J. Rassa, 1998, Virology.

An AGM Model for Changes in Complement during Pregnancy: Neutralization of Influenza Virus by Serum Is Diminished in Late Third Trimester

G. Parks, Anne E. Mayer, 2014, PloS one.

Growth sensitivity of a recombinant simian virus 5 P/V mutant to type I interferon differs between tumor cell lines and normal primary cells.

G. Parks, S. Cramer, P. Dillon, 2005, Virology.

TLR3-dependent upregulation of RIG-I leads to enhanced cytokine production from cells infected with the parainfluenza virus SV5.

G. Parks, Mary J Manuse, 2010, Virology.

Pivotal Advance: Nonfunctional lung effectors exhibit decreased calcium mobilization associated with reduced expression of ORAI1

G. Parks, Sharad K Sharma, M. Alexander-Miller, 2010, Journal of leukocyte biology.

Engineered Expression of the TLR5 Ligand Flagellin Enhances Paramyxovirus Activation of Human Dendritic Cell Function

G. Parks, S. Mizel, M. Alexander-Miller, 2008, Journal of Virology.

Simian Virus 5 Is a Poor Inducer of Chemokine Secretion from Human Lung Epithelial Cells: Identification of Viral Mutants That Activate Interleukin-8 Secretion by Distinct Mechanisms

G. Parks, V. A. Young, 2003, Journal of Virology.

Exchange of P/V genes between two non-cytopathic simian virus 5 variants results in a recombinant virus that kills cells through death pathways that are sensitive to caspase inhibitors.

G. Parks, P. Dillon, M. Alexander-Miller, 2006, The Journal of general virology.

Apoptosis induction and interferon signaling but not IFN-beta promoter induction by an SV5 P/V mutant are rescued by coinfection with wild-type SV5.

G. Parks, J. Grayson, E. Wansley, 2003, Virology.

High Avidity CD8+ T Cells Are the Initial Population Elicited Following Viral Infection of the Respiratory Tract1

G. Parks, M. Alexander-Miller, Peter M. Gray, 2003, The Journal of Immunology.

A Novel CD8-Independent High-Avidity Cytotoxic T-Lymphocyte Response Directed against an Epitope in the Phosphoprotein of the Paramyxovirus Simian Virus 5

G. Parks, M. Alexander-Miller, P. M. Gray, 2001, Journal of Virology.

High avidity cytotoxic T lymphocytes to a foreign antigen are efficiently activated following immunization with a recombinant paramyxovirus, simian virus 5.

G. Parks, M. Alexander-Miller, 2002, The Journal of general virology.

The neutralizing capacity of antibodies elicited by parainfluenza virus infection of African Green Monkeys is dependent on complement.

G. Parks, J. B. Johnson, Anne E. Mayer, 2014, Virology.

Paramyxovirus activation and inhibition of innate immune responses.

G. Parks, M. Alexander-Miller, 2013, Journal of molecular biology.

Mumps virus inhibits migration of primary human macrophages toward a chemokine gradient through a TNF-alpha dependent mechanism.

G. Parks, Caitlin M. Briggs, Anne E. Mayer, 2012, Virology.

Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge

G. Parks, S. Mizel, N. Kock, 2011, Virology.

Role for the Paramyxovirus Genomic Promoter in Limiting Host Cell Antiviral Responses and Cell Killing

G. Parks, Mary J Manuse, 2009, Journal of Virology.

The Paramyxoviruses Simian Virus 5 and Mumps Virus Recruit Host Cell CD46 To Evade Complement-Mediated Neutralization

G. Parks, J. B. Johnson, Ken W Grant, 2009, Journal of Virology.

A Hyperfusogenic F Protein Enhances the Oncolytic Potency of a Paramyxovirus Simian Virus 5 P/V Mutant without Compromising Sensitivity to Type I Interferon

G. Parks, Maria D. Gainey, Mary J Manuse, 2008, Journal of Virology.

Differential mechanisms of complement-mediated neutralization of the closely related paramyxoviruses simian virus 5 and mumps virus.

G. Parks, J. B. Johnson, G. Capraro, 2008, Virology.

Virus growth and antibody responses following respiratory tract infection of ferrets and mice with WT and P/V mutants of the paramyxovirus Simian Virus 5

G. Parks, N. Kock, J. B. Johnson, 2008, Virology.

Paramyxovirus-Induced Shutoff of Host and Viral Protein Synthesis: Role of the P and V Proteins in Limiting PKR Activation

G. Parks, P. Dillon, K. M. Clark, 2007, Journal of Virology.

Role for the Phosphoprotein P Subunit of the Paramyxovirus Polymerase in Limiting Induction of Host Cell Antiviral Responses

G. Parks, P. Dillon, 2007, Journal of Virology.

Variants of the paramyxovirus Simian virus 5 with accelerated or delayed viral gene expression activate proinflammatory cytokine synthesis.

G. Parks, P. Dillon, V. A. Young, 2006, Virology.

A Simian Virus 5 (SV5) P/V Mutant Is Less Cytopathic than Wild-Type SV5 in Human Dendritic Cells and Is a More Effective Activator of Dendritic Cell Maturation and Function

G. Parks, M. Alexander-Miller, S. Arimilli, 2006, Journal of Virology.

Abortive versus Productive Viral Infection of Dendritic Cells with a Paramyxovirus Results in Differential Upregulation of Select Costimulatory Molecules

G. Parks, M. Alexander-Miller, Sharmila S Pejawar, 2005, Journal of Virology.

Positive- and negative-acting signals combine to determine differential RNA replication from the paramyxovirus simian virus 5 genomic and antigenomic promoters.

G. Parks, M. Keller, 2003, Virology.

Naturally Occurring Substitutions in the P/V Gene Convert the Noncytopathic Paramyxovirus Simian Virus 5 into a Virus That Induces Alpha/Beta Interferon Synthesis and Cell Death

G. Parks, E. Wansley, 2002, Journal of Virology.

RNA Replication from the Simian Virus 5 Antigenomic Promoter Requires Three Sequence-Dependent Elements Separated by Sequence-Independent Spacer Regions

G. Parks, S. Murphy, M. Keller, 2001, Journal of Virology.

A Functional Antigenomic Promoter for the Paramyxovirus Simian Virus 5 Requires Proper Spacing between an Essential Internal Segment and the 3′ Terminus

G. Parks, S. Murphy, Yasuhiko Ito, 1998, Journal of Virology.

Genome nucleotide lengths that are divisible by six are not essential but enhance replication of defective interfering RNAs of the paramyxovirus simian virus 5.

G. Parks, S. K. Murphy, 1997, Virology.

Site-specific mutations at a picornavirus VP3/VP1 cleavage site disrupt in vitro processing and assembly of capsid precursors

G. Parks, A. Palmenberg, G D Parks, 1987, Journal of virology.

Mapping ofaRegion oftheParamyxovirus LProtein Required fortheFormation ofaStable Complex withthe Viral Phosphoprotein P

G. Parks, 1994 .

Aptamer–gold nanoparticle conjugates for the colorimetric detection of arboviruses and vector mosquito species

George W. Jackson, Truong D. Nguyen-Huu, G. Parks, 2019, RSC advances.

A Novel Factor I Activity in Nipah Virus Inhibits Human Complement Pathways through Cleavage of C3b

G. Parks, V. Borisevich, B. Rockx, 2014, Journal of Virology.

The Bordetella pertussis Bps polysaccharide enhances lung colonization by conferring protection from complement‐mediated killing

G. Parks, N. Kock, R. Deora, 2014, Cellular microbiology.

Point Mutations in the Paramyxovirus F Protein That Enhance Fusion Activity Shift the Mechanism of Complement-Mediated Virus Neutralization

G. Parks, A. Schmitt, J. B. Johnson, 2013, Journal of Virology.

Delivery of a novel membrane-anchored Fc chimera enhances NK cell-mediated killing of tumor cells and persistently virus-infected cells

G. Parks, A. Copik, J. Oyer, 2023, PloS one.

Complement Inhibitors Vitronectin and Clusterin Are Recruited from Human Serum to the Surface of Coronavirus OC43-Infected Lung Cells through Antibody-Dependent Mechanisms

G. Parks, C. Fox, 2021, Viruses.

Parainfluenza virus 5 upregulates CD55 expression to produce virions with enhanced resistance to complement-mediated neutralization.

G. Parks, Yujia Li, J. B. Johnson, 2016, Virology.

Role of NH2-terminal positively charged residues in establishing membrane protein topology.

R. Lamb, G. Parks, 1993, The Journal of biological chemistry.

Structural requirements in the membrane-spanning domain of the paramyxovirus HN protein for the formation of a stable tetramer.

G. Parks, S. Pohlmann, 1995, Virology.

Relationship of Theiler's murine encephalomyelitis viruses to the cardiovirus genus of picornaviruses.

G. Parks, S. Nitayaphan, R. Roos, 1986, Intervirology.

Broad-Spectrum, Potent, and Durable Ceria Nanoparticles Inactivate RNA Virus Infectivity by Targeting Virion Surfaces and Disrupting Virus–Receptor Interactions

Craig J. Neal, G. Parks, C. Drake, 2023, Molecules.